Get started
Gilead Sciences, Inc.

GILD range bound, unlikely to break-out

176
GILD

Remdesivir may help GILD breakout from multi-year range-bound pattern, however giving the limited income from it in the short-term, I would reckon we don't break out.
Fundamentals500
Fundamental AnalysisSupport and ResistanceTrend Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Fundamental AnalysisSupport and ResistanceTrend Analysis
Fundamentals500

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.